CytomX Therapeutics CTMX Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's goodwill?
- CytomX Therapeutics (CTMX) reported goodwill of $949K in Q1 2026.
- How has CytomX Therapeutics's goodwill changed year-over-year?
- CytomX Therapeutics's goodwill decreased by 0.0% year-over-year, from $949K to $949K.
- What is the long-term trend for CytomX Therapeutics's goodwill?
- Over 5 years (2020 to 2025), CytomX Therapeutics's goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $949K to $949K.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.